Presentation TCT 2018 Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif September 22, 2018
Presentation TCT 2018 Cedars-Sinai Medical Center (USA Presenter: Tarun Chakravarty September 22, 2018
Presentation TCT 2018 Erasmus University (The Netherlands) Presenter: Herbert Kroon September 22, 2018
Presentation TCT 2018 TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves Presenter: Steven R. Bailey, Patrick W. Serruys, Julia Seeger September 22, 2018
Presentation TCT 2018 A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery Presenter: Alexandra J. Lansky, Axel Linke, Samir R. Kapadia September 22, 2018
Presentation TCT 2018 TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands Presenter: Alain G. Cribier, Helene Eltchaninoff, Herbert Kroon September 21, 2018
Presentation TCT 2018 Carotid Artery Disease Technical Considerations: Embolic Protection Options and Selection Presenter: Aman B. Patel, Kenneth Rosenfield, Alexander A. Khalessi September 21, 2018
Presentation TCT 2018 Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial Presenter: Tamim Nazif September 21, 2018
Presentation TCT 2018 Full Body Embolic Protection During TAVR (Filterlex) Presenter: Giora Weisz September 21, 2018
Presentation TCT 2018 Atherotomy (Cutting, Scoring, Lithotrispy), Atherectomy (Rotational, Orbital, Laser), and Embolic Protection Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Robert T. Pyo September 21, 2018
News Conference News TCT 2017 Experts Debate: Should Cerebral Protection Be Used for All TAVRs? Todd Neale November 09, 2017
Presentation TCT 2017 Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto November 01, 2017
Presentation TCT 2017 Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia November 01, 2017
Presentation TCT 2017 FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices Presenter: Martin B. Leon, Changfu Wu, John C Laschinger October 31, 2017
Presentation TCT 2017 Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences Presenter: Martin B. Leon, Changfu Wu October 31, 2017
Presentation TCT 2017 TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger October 31, 2017
Presentation TCT 2017 Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek October 30, 2017
Presentation TCT 2017 Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger October 30, 2017
Presentation TCT 2017 Atherotomy, Atherectomy (Rotational, Orbital, Laser), and Embolic Protection Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Robert T. Pyo October 29, 2017